More Post from the Author
- Evolve acquires Guestworks portfolio from Vacasa in strategic asset transaction
- Gloo Announces Partial Exercise of Underwriters' Option to Purchase Additional Shares
- CGTN: G20 prichdza do Afriky: na vyzva k jednote namiesto roztrietenosti
- CGTN: G20 kommt erstmals nach Afrika: China ruft zu Einheit statt Spaltung auf
- ModuleMD Showcases Advanced AI-Driven Allergy Solutions at ACAAI 2025
In light of the recent PGT-A class action lawsuit filings in a court in Florida, Vitrolife Group issues the following statement
GOTHENBURG, Sweden, March 5, 2025 /PRNewswire/ -- Vitrolife Group is aware that a PGT-A class action lawsuit has been filed against Vitrolife AB (publ), Vitrolife Inc and Igenomix USA, Inc in the court of the Southern District of Florida, although no formal complaint has been served yet. During the fourth quarter of 2024, similar class actions were initiated in the US against other peer companies providing PGT-A testing services. Vitrolife Group will, together with our legal counsel in the US, evaluate the class action and its potential scope and update the market in due course when further information is available.
Gothenburg, 5 March 2025
VITROLIFE AB (publ)
Bronwyn Brophy O'Connor, CEO
Contact:
Amelie Wilson, Investor Relations, [emailprotected]
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
In light of the recent PGT-A class action lawsuit filings in a court in Florida, Vitrolife Group issues the following statement |
SOURCE Vitrolife AB (publ)

More Post from the Author
- Evolve acquires Guestworks portfolio from Vacasa in strategic asset transaction
- Gloo Announces Partial Exercise of Underwriters' Option to Purchase Additional Shares
- CGTN: G20 prichdza do Afriky: na vyzva k jednote namiesto roztrietenosti
- CGTN: G20 kommt erstmals nach Afrika: China ruft zu Einheit statt Spaltung auf
- ModuleMD Showcases Advanced AI-Driven Allergy Solutions at ACAAI 2025
